Cargando…

A stonemason with accelerated silicosis in the setting of tumour necrosis factor alpha inhibitor therapy

We present the case of a 26‐year‐old stonemason with accelerated silicosis in the setting of treatment for psoriasis with the tumour necrosis factor alpha (TNF‐alpha) inhibitor adalimumab. Accelerated silicosis is an important occupational lung disease with a poor prognosis and limited treatment opt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baird, Timothy, Putt, Michael, Dettrick, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2016
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970307/ https://www.ncbi.nlm.nih.gov/pubmed/27516887 http://dx.doi.org/10.1002/rcr2.171

Ejemplares similares

Disabling Orthostatic Headache after Penetrating Stonemason Pencil Injury to the Sacral Region
por: Brembilla, Carlo, et al.
Publicado: (2015)

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022)

Case of accelerated silicosis in a sandblaster
por: HUTYROVÁ, Beáta, et al.
Publicado: (2014)

Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis
por: Gould, David, et al.
Publicado: (2007)

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996)

Metabolic effects of tumour necrosis factor alpha in NMRI mice.
por: Mahony, S. M., et al.
Publicado: (1990)

Accelerated silicosis and silico‐tuberculosis: A difficult diagnosis
por: Khemakhem, Rim, et al.
Publicado: (2022)

Cell-Based Therapy for Silicosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2016)

Tumor necrosis factor gene polymorphisms are associated with silicosis: a systemic review and meta-analysis
por: Zhang, Min, et al.
Publicado: (2019)

Silicosis
por: Henderson, Fergus L.
Publicado: (1929)

Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast.
por: Pusztai, L., et al.
Publicado: (1994)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
por: Tse, Brian W. C., et al.
Publicado: (2012)

Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha
por: Stanilov, Noyko, et al.
Publicado: (2014)

Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
por: Ruder, Barbara, et al.
Publicado: (2019)

Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus.
por: Torzecka, Jolanta Dorota, et al.
Publicado: (2003)

Effect of Tumour Necrosis Factor-Alpha on Estrogen Metabolic Pathways in Breast Cancer Cells
por: Kamel, Marwa, et al.
Publicado: (2012)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

Primary Cutaneous B-cell Lymphoma Leg-type Related to a Tumour Necrosis Factor Alpha Inhibitor
por: BELKAÏD, Samy, et al.
Publicado: (2022)

Silicosis : revisión bibliográfica /
por: Rodríguez Lozano, María Griselda
Publicado: (1993)

Tumour Necrosis Factor-alpha and Nuclear Factor-kappa B Gene Variants in Sepsis
por: Acar, Leyla, et al.
Publicado: (2018)

The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoids
por: Cecilio, C. A., et al.
Publicado: (1997)

The promoting effect of tumour necrosis factor alpha in radiation-induced cell transformation.
por: Guo, R. F., et al.
Publicado: (1998)

Opioid receptor expression on neutrophils: effect of tumour necrosis factor alpha treatment
por: Schmidt, A, et al.
Publicado: (2007)

Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis
por: Neniskyte, Urte, et al.
Publicado: (2014)

Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma
por: Brierly, Gary, et al.
Publicado: (2023)

Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha).
por: Simonitsch, I., et al.
Publicado: (1998)

Acute Silicosis
por: Scott, G. A.
Publicado: (1964)

An eruption of silicosis.
por: Wakefield, J
Publicado: (2000)

Silicosis and Asbestosis
Publicado: (1939)

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
por: de Wilt, J H W, et al.
Publicado: (2000)

Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in rats.
por: van der Zee, J., et al.
Publicado: (1995)

A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
por: Lee, Seulkee, et al.
Publicado: (2021)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis
por: Werlang, Monia E., et al.
Publicado: (2017)

A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice
por: Jani, Meghna, et al.
Publicado: (2016)

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
por: De Bandt, Michel, et al.
Publicado: (2005)

Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy
por: Schultz, Brittney, et al.
Publicado: (2018)

Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1995)

Tumour necrosis factor-alpha and interleukin-8 inhibit neutrophil migration in vitro and in vivo
por: Cunha, F. Q., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_iirhumpabf2rhnevsulepkkkbg